PBPIA
Pivotal bioVenture Partners Investment Advisor Portfolio holdings
AUM
$173M
1-Year Est. Return
64.93%
1 Year Est. Return
+64.93%
AUM
$173M
AUM Growth
+$11.6M
(+7.2%)
Holding
13
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vaxcyte
PCVX
$6.06B
| $49.4M | 28.58% |
1,372,425
+67,300
|
|
||
2
Oculis Holding
OCS
$1.13B
| $40.4M | 23.38% |
2,300,774
|
|
||
3
Arcutis Biotherapeutics
ARQT
$3.81B
| $40M | 23.11% |
2,120,508
|
|
||
|
ZBIO
4
Zenas BioPharma
ZBIO
$2.03B
| $17.3M | 10% |
779,045
|
|
||
5
Trevi Therapeutics
TRVI
$1.74B
| $11.5M | 6.65% |
1,256,782
+110,672
|
|
||
6
Immunome
IMNM
$1.85B
| $5.88M | 3.4% |
+502,512
|
|
||
|
BIOA
7
BioAge Labs
BIOA
$377M
| $3.84M | 2.22% |
653,374
|
|
||
8
Recursion Pharmaceuticals
RXRX
$2.54B
| $2.91M | 1.68% |
595,518
|
|
||
9
Rallybio
RLYB
$28.3M
| $1.2M | 0.69% |
2,404,644
|
|
||
10
Bolt Biotherapeutics
BOLT
$9.89M
| $503K | 0.29% |
94,573
|
|
||
|
INZY
11
DELISTED
Inozyme Pharma
INZY
| – | – |
-4,494,851
|
|
||
12
IO Biotech
IOBT
$49.2M
| – | – |
-864,197
|
|
||
|
VIGL
13
DELISTED
Vigil Neuroscience
VIGL
| – | – |
-560,595
|
|